NAYA Biosciences, Inc.
NAYANASDAQHealthcare
$2.20
+$0.17(+8.37%)
Market Cap$1465323
P/E Ratio—
52W High$17.04
52W Low$1.38
NAYA Biosciences, Inc. (NAYA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NAYA · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2025Report Date: Apr 22, 2025EPS Actual
-$11.71
Est. -$42.00 · +72.1%
Revenue
$0.00B
Est. $0.00B · +12.4%
Fiscal Period
Q2 FY2025
FY ends December
Report Date
Apr 22, 2025
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
NAYA reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$93.32
Rev. $1001.5B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$93.32
Rev. Est.$1001.5B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2025 | Aug 12, 2025 | — | — | — | — | — | — |
| ▲ Q2 FY2025 | Apr 22, 2025 | -$42.00 | -$11.71 | +72.1% | $0.00B | $0.00B | +12.4% |
| ▼ Q4 FY2024 | Nov 19, 2024 | -$1.08 | -$5.04 | -366.7% | $0.00B | $0.00B | -64.5% |
| ▲ Q3 FY2024 | Aug 14, 2024 | -$1.68 | -$0.62 | +63.1% | $0.00B | $0.00B | -43.9% |
| ▲ Q2 FY2024 | May 15, 2024 | -$1.92 | -$0.42 | +78.1% | $0.00B | $0.00B | -42.2% |
| ▲ Q4 FY2023 | Dec 31, 2023 | -$10.44 | -$0.80 | +92.3% | $0.00B | $0.00B | -28.3% |
| ▲ Q3 FY2023 | Sep 30, 2023 | -$11.88 | -$0.35 | +97.0% | $0.00B | $0.00B | -2.2% |
| ▲ Q2 FY2023 | Jun 30, 2023 | -$50.40 | -$0.76 | +98.5% | $0.00B | $0.00B | -29.8% |
Q3 FY2025
Aug 12, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Apr 22, 2025Beat
EPS Actual
-$11.71
EPS Est.
-$42.00
EPS Surpr.
+72.1%
Revenue
$0.00B
Q4 FY2024
Nov 19, 2024Miss
EPS Actual
-$5.04
EPS Est.
-$1.08
EPS Surpr.
-366.7%
Revenue
$0.00B
Q3 FY2024
Aug 14, 2024Beat
EPS Actual
-$0.62
EPS Est.
-$1.68
EPS Surpr.
+63.1%
Revenue
$0.00B
Q2 FY2024
May 15, 2024Beat
EPS Actual
-$0.42
EPS Est.
-$1.92
EPS Surpr.
+78.1%
Revenue
$0.00B
Q4 FY2023
Dec 31, 2023Beat
EPS Actual
-$0.80
EPS Est.
-$10.44
EPS Surpr.
+92.3%
Revenue
$0.00B
Q3 FY2023
Sep 30, 2023Beat
EPS Actual
-$0.35
EPS Est.
-$11.88
EPS Surpr.
+97.0%
Revenue
$0.00B
Q2 FY2023
Jun 30, 2023Beat
EPS Actual
-$0.76
EPS Est.
-$50.40
EPS Surpr.
+98.5%
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2025 | Apr 22, 2025 | +72.1% | $1.84 | $1.80 | -2.17% |
| ▼ Q4 FY2024 | Nov 19, 2024 | -366.7% | $9.74 | $9.76 | +0.21% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +63.1% | $11.23 | $10.73 | -4.45% |
| ▲ Q2 FY2024 | May 15, 2024 | +78.1% | $13.44 | $12.84 | -4.46% |
| ▲ Q4 FY2023 | Dec 31, 2023 | +92.3% | $16.20 | $15.36 | -5.19% |
| ▲ Q3 FY2023 | Sep 30, 2023 | +97.0% | $9.48 | $9.01 | -4.96% |
| ▲ Q2 FY2023 | Jun 30, 2023 | +98.5% | $49.68 | $48.05 | -3.28% |
| ▲ Q1 FY2023 | Mar 31, 2023 | +97.3% | $144.07 | $153.36 | +6.45% |
Q2 FY2025-2.17%
Report Date
Apr 22, 2025
EPS Beat/Miss
+72.1%
Price Before
$1.84
Price After
$1.80
Q4 FY2024+0.21%
Report Date
Nov 19, 2024
EPS Beat/Miss
-366.7%
Price Before
$9.74
Price After
$9.76
Q3 FY2024-4.45%
Report Date
Aug 14, 2024
EPS Beat/Miss
+63.1%
Price Before
$11.23
Price After
$10.73
Q2 FY2024-4.46%
Report Date
May 15, 2024
EPS Beat/Miss
+78.1%
Price Before
$13.44
Price After
$12.84
Q4 FY2023-5.19%
Report Date
Dec 31, 2023
EPS Beat/Miss
+92.3%
Price Before
$16.20
Price After
$15.36
Q3 FY2023-4.96%
Report Date
Sep 30, 2023
EPS Beat/Miss
+97.0%
Price Before
$9.48
Price After
$9.01
Q2 FY2023-3.28%
Report Date
Jun 30, 2023
EPS Beat/Miss
+98.5%
Price Before
$49.68
Price After
$48.05
Q1 FY2023+6.45%
Report Date
Mar 31, 2023
EPS Beat/Miss
+97.3%
Price Before
$144.07
Price After
$153.36
Avg Beat Reaction-2.58%
Avg Miss Reaction+0.21%
Beat Rate7 / 8 quarters
Largest Move+6.45% (Q1 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NAYA ends December
NAYA Biosciences, Inc. (NAYA) most recently reported earnings on April 22, 2025 for Q2 FY2025, posting EPS of $-11.71 — beating the analyst consensus of $-42.00 by +72.1%. The next NAYA earnings date is expected around September 1, 2026.
Each quarter, investors track NAYA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NAYA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NAYA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NAYA earnings · 5 questionsNAYA Biosciences, Inc.'s next earnings report is expected around September 1, 2026. NAYA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NAYA historically reports after market close (AMC).
NAYA earnings datewhen is NAYA earningsNAYA next earnings datewhen does NAYA report earningsNAYA earnings calendar
▸ Source: FMP · NAYA Biosciences, Inc. SEC filings · US GAAP · NAYA Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026